DC67515 · Updated 27 October 2026
CICL-207
Product Datasheet
CICL-207 is a constrained ionizable lipid described in US20250127728A1 for targeted lipid-nanoparticle research. The patent evaluates reporter-mRNA delivery, immune-cell delivery and short-term tolerability in animal models. The results apply to the studied complete nanoparticles and their targeting ligands.
| CAS No. | Not available |
| Chemical Name | CICL-207 |
| Synonyms | CICL207， CICL 207 |
| SMILES | CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC)CC(=O)OC[C@@H]1C[C@@H](OC(=O)CC(COC(=O)CCCCCCCC)COC(=O)CCCCCCCC)CN1C(=O)OCCN(C)C |
| Formula | C56H100N2O14 |
| M.Wt | 1025.416 |
| Purity | >95% by ELSD-HPLC |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication |
Research evidence
Read detailed Formulation & Performance
Specifications are catalog specifications, not batch test results.